CYTK

Insider trade Sale by Kaye Edward M. MD

12h ago

Insider trade Sale by PARSHALL B LYNNE

12h ago

Insider trade Sale by Blum Robert I (President & CEO)

4d ago

SEC filing CYTK Stockholders Elect 3 Directors, Approve 1M Share ESPP Increase, Ratify EY

5d ago

News Ionis, Alnylam, BioMarin up as Citi starts at Buy on catalyst and growth outlook

13d ago

News FDA Pushes Potential Approval For Cytokinetics' Experimental Heart Drug By Three Months

14d ago

News Why Cytokinetics (CYTK) Stock Price Was Down 17% on Thursday

14d ago

News NVIDIA To Rally Over 39%? Here Are 10 Top Analyst Forecasts For Thursday

14d ago

News Heart Disease-Focused Cytokinetics Operations Are On Track Despite Acquisition Uncertainty, Analysts Observe

14d ago

Short volume Short volume 77% of volume (3.1σ)

17d ago

Insider trade Sale by Robert I Blum (President & CEO)

18d ago

News Cytokinetics prices upsized $700M equity raise at $71 per share

26d ago

News Cytokinetics outlines $830M-$870M 2026 operating expense range while advancing MYQORZO Germany launch

27d ago

Insider trade Sale by Fady Ibraham Malik (EVP Research & Development)

27d ago

Insider trade Sale by John T Henderson

27d ago

Insider trade Sale by Sung Lee (EVP, Chief Financial Officer)

27d ago

Insider trade Sale by Wendell Wierenga

27d ago

Insider trade Sale by Andrew Callos (EVP, Chief Commercial Officer)

27d ago

SEC filing CYTK Reports $4.8M Net Product Revenue, $1.1B Cash, Launches MYQORZO in U.S., EC Approval, ACACIA-HCM Meets Dual Endpoints, FDA NDA Accepted with Nov 14 PDUFA, ~275 HCPs Prescribe to 680 Patients, Germany Launch Q2 2026

27d ago

Insider trade Sale by Andrew Callos (EVP, Chief Commercial Officer)

28d ago

Insider trade Sale by Andrew Callos (EVP, Chief Commercial Officer)

32d ago

Insider trade Sale by Robert I Blum (President & CEO)

33d ago

Insider trade Sale by Fady Ibraham Malik (EVP Research & Development)

38d ago

Insider trade Sale by Fady Ibraham Malik (EVP Research & Development)

41d ago

Insider trade Sale by Andrew Callos (EVP, Chief Commercial Officer)

47d ago